It's How Medicine Should Be®

Translate

French German Italian Portuguese Russian

Cutaneous T-Cell Lymphoma Study: Monoclonal Antibody Versus Vorinostat

Clinical Trial Title: 
Open-Label, Multi-Center, Randomized Study of a Monoclonal Antibody Versus Vorinostat in Subjects with Previously Treated Cutaneous T-Cell Lymphoma
Clinical Trial Protocol ID: 
12050905
Clinical Trial Investigator Name: 
Michael D. Tharp, MD
Clinical Trial Protocol Description: 

Rush Dermatology seeks volunteers with a diagnosis of CTCL (cutaneous T-cell lymphoma) or mycosis fungoides for a clinical trial testing an investigational medication. All office visits and treatments are provided free of charge.

Clinical Trial Eligibility Criteria: 

You may be eligible to participate in this study if you:

  • Are 18 years of age or older
  • Have had a diagnosis of CTCL or mycosis fungoides
  • Have failed treatment with at least one other systemic therapy

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.

Clinical Trial Area: 
Dermatology
Contact Phone: 
(312) 563-4001
Contact Name: 
Carmen Petrizzo or Danica Uzelac